NCT04519775

Brief Summary

The purpose of this study is to determine the efficacy of an entirely virtual version of the home-based cognitive self-management program "HOBSCOTCH." It will test whether HOBSCOTCH can be delivered nationally from a distance utilizing e-health tools (telephone, computer, and phone).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 17, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 20, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

November 12, 2020

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 26, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 19, 2024

Completed
Last Updated

July 1, 2025

Status Verified

June 1, 2025

Enrollment Period

3.9 years

First QC Date

August 17, 2020

Last Update Submit

June 26, 2025

Conditions

Keywords

Epilepsy Memory ProblemsSelf-Management

Outcome Measures

Primary Outcomes (2)

  • Change in quality of life

    The researchers will use the Quality of Life in Epilepsy (QOLIE-31). This validated tool contains 16 multi-item scales which assess health related quality of life, emotional well-being, memory and attention deficits, medication effects, seizure control, psychosocial functioning, and health perception. Scores range from 0 to 100, with a higher score reflecting a higher quality of life.

    Baseline and at months 3, 6, 9, 12

  • Change in cognitive function

    The researchers will use the Cognitive Function sub-scale of the NeuroQOL. This is a brief validated tool developed by the NIH for use in patients with neurological disease. Scores range from 8 to 40, with a higher score indicating better reported cognitive functioning.

    Baseline and at months 3, 6, 9, 12

Secondary Outcomes (7)

  • Change in depression

    Baseline and at months 3, 6, 9, 12

  • Change in self-management practices

    Baseline and at months 3, 6, 9, 12

  • Changes in self-reported seizure frequency

    Ongoing through entire study baseline - 12 months

  • Changes in medication adherence

    Ongoing through entire study baseline - 12 months, and at baseline and at months 3, 6, 9, 12

  • Changes in health confidence

    Baseline and at months 3, 6, 9, 12

  • +2 more secondary outcomes

Study Arms (2)

HOBSCOTCH-V (virtual)

EXPERIMENTAL

Participants will receive the HOBSCOTCH intervention consisting of 1:1 sessions delivered once per week, including: * 1 pre-HOBSCOTCH Session (on webcam) * 1 educational session (on webcam) * 6 telephone sessions * 1 wrap-up session (webcam or telephone) Participants will also receive 3 booster sessions, via webcam or telephone, once per month.

Behavioral: Home Based Self-management and Cognitive Training Changes lives (HOBSCOTCH)

Control

OTHER

Participants will be wait listed and will receive HOBSCOTCH-V (above) following a 6 month wait period.

Behavioral: Home Based Self-management and Cognitive Training Changes lives (HOBSCOTCH)

Interventions

HOBSCOTCH is a home-based self-management program to treat cognitive symptoms and improve quality of life, while minimizing the barriers of access to care. The program is based on Problem Solving Therapy (PST) and teaches problem solving strategies and compensatory mechanisms to help manage cognitive dysfunction and enhance quality of life.

Also known as: HOBSCOTCH
ControlHOBSCOTCH-V (virtual)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18+
  • Diagnosis of epilepsy, with controlled or uncontrolled seizures
  • Subjective memory complaints
  • No changes in antiepileptic and antidepressant medication regimen for 1 month, however brief discontinuation of antiepileptic medicine for inpatient video EEG evaluation is acceptable
  • Literate
  • Telephone access
  • Internet access

You may not qualify if:

  • Subjects self-reporting a dementing illness or a mention of a dementing illness in their medical record
  • Severe mental disability or estimated IQ less than 70 per clinical judgement
  • Significant visual impairment precluding reading or writing
  • No reliable telephone or internet access
  • No diagnosis of epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, 03756, United States

Location

Related Publications (2)

  • Caller TA, Secore KL, Ferguson RJ, Roth RM, Alexandre FP, Henegan PL, Harrington JJ, Jobst BC. Design and feasibility of a memory intervention with focus on self-management for cognitive impairment in epilepsy. Epilepsy Behav. 2015 Mar;44:192-4. doi: 10.1016/j.yebeh.2014.12.036. Epub 2015 Feb 27.

    PMID: 25731132BACKGROUND
  • Caller TA, Ferguson RJ, Roth RM, Secore KL, Alexandre FP, Zhao W, Tosteson TD, Henegan PL, Birney K, Jobst BC. A cognitive behavioral intervention (HOBSCOTCH) improves quality of life and attention in epilepsy. Epilepsy Behav. 2016 Apr;57(Pt A):111-117. doi: 10.1016/j.yebeh.2016.01.024. Epub 2016 Mar 2.

    PMID: 26943948BACKGROUND

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Barbara Jobst, MD

    Dartmouth-Hitchcock Medical Center and Dartmouth College

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Physician, Neurology

Study Record Dates

First Submitted

August 17, 2020

First Posted

August 20, 2020

Study Start

November 12, 2020

Primary Completion

September 26, 2024

Study Completion

November 19, 2024

Last Updated

July 1, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations